
Timing of Cancer Treatment Could Improve Outcomes
A study suggests that administering immune checkpoint inhibitors earlier in the day, before 3 p.m., significantly improves survival outcomes for patients with extensive-stage small cell lung cancer, highlighting the potential of chronotherapy to optimize cancer treatment by aligning it with the body's circadian rhythms.


